SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer - Wikidata - wikimedia - TriplyDB

SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer

SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer

http://www.wikidata.org/entity/Q35021702

about

FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy Role of solute carrier transporters in pancreatic cancer: a review.Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.Impressions of pharmacogenomic testing among Certified Registered Nurse Anesthetists: a mixed-method study.Solute carrier transporters: potential targets for digestive system neoplasms.Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients.Hypermethylation of protocadherin γ subfamily A12 and solute carrier family 19 A 1 promoters contributes to the occurrence and metastasis of colorectal cancer.

P2860

Q26851060-B79EF79A-4614-42F7-B5FA-1DF6BB809B69 Q38236028-2854C3B4-39C5-4DD9-A965-BDB97BF84FFC Q38933314-E8743E8C-F272-4A26-95C8-9C9A2CEF58C4 Q39882314-EC36C9EF-50FD-47C6-B3BE-2AAD8F1A5522 Q49667930-604066B6-2868-4E64-8F5C-990A97CDE304 Q50042411-A9F0978E-39EB-4B38-8A50-4E4234707290 Q55263360-77B809A1-5E7A-4A1E-B382-649B587D6CE2

P2860

SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer

http://www.wikidata.org/entity/Q35021702

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

SLCO1B1 and SLC19A1 gene varia ...... f metastatic colorectal cancer

@ast

SLCO1B1 and SLC19A1 gene varia ...... f metastatic colorectal cancer

@en

type

label

SLCO1B1 and SLC19A1 gene varia ...... f metastatic colorectal cancer

@ast

SLCO1B1 and SLC19A1 gene varia ...... f metastatic colorectal cancer

@en

prefLabel

SLCO1B1 and SLC19A1 gene varia ...... f metastatic colorectal cancer

@ast

SLCO1B1 and SLC19A1 gene varia ...... f metastatic colorectal cancer

@en

P1433

Q35021702-9916B99C-3A86-4F21-9318-F542BEB480EE

P1476

Q35021702-62246E10-ED24-4917-A1AE-A2FB650077B7

P2093

Q35021702-09C3CF7E-BB7E-45F3-B76C-C67208CE296F

Q35021702-12D305E6-1483-4FD8-8CB0-73B4FDED514B

Q35021702-1A6A4D8F-79DD-4814-9278-26A3229553C0

Q35021702-3B43F23B-520E-4371-BF58-66BEF9A665E9

Q35021702-3DED809F-159F-4A90-A08E-E149D340C046

Q35021702-431E2DF7-D5D6-481F-83A8-0AD98670A86D

Q35021702-4D52A33F-8683-4DFC-B629-4217901830F3

Q35021702-675FF931-BF30-4672-A3B7-303C2E48D8A2

Q35021702-7AC075DD-CE86-439C-905D-1A752F329D31

Q35021702-8B896D70-03DA-4255-9E6C-641E5E5E7E8A

P2860

Q35021702-0B58BE48-CF05-4B8B-8071-5354CFB7FE81

Q35021702-108AC857-53C8-4ECB-B83B-B310FBBD79C6

Q35021702-1B06A452-920B-43CB-8282-5EDF9083EA39

Q35021702-2561CB2B-C18C-4814-AD3D-38BE3FB2530D

Q35021702-2F3B813B-F903-41D6-993C-CB6D3F82467D

Q35021702-36E13A58-5766-49DD-BDBF-5EBB7C93261B

Q35021702-49A359CD-45FC-475D-81B8-5E7C5EE5A79B

Q35021702-4D037D01-CDFD-437C-AE4A-82843D8B7477

Q35021702-5243A4B1-C06D-4B63-A6E1-47568EBA9AD2

Q35021702-52F8C058-0BC8-4BB0-8762-2A4169D988A1

P304

Q35021702-A3CF81DB-EDF0-4856-87F5-8E2D2045703F

P31

Q35021702-2788B7D4-308A-4328-98E9-E4241243676F

P356

Q35021702-61B2BB11-9A56-4DAD-A354-181E71335FB0

P407

Q35021702-B89BB753-16E9-4790-84E2-3821BA2A76BD

P433

Q35021702-9138DA44-7263-43C2-A242-35FCF0D7ED68

P478

Q35021702-DBE35EDF-62B9-4529-A934-A67DB0F8EC15

P577

Q35021702-F8E02A00-E9C1-4956-8822-03776E846F05

P5875

Q35021702-BA37A19B-98B0-412D-9584-06A7D2F47E8A

P698

Q35021702-27939087-70EA-4596-B280-8C3984C19BDA

P921

Q35021702-A12E7BF6-FBAB-4AE0-96C1-FBF62AE68E06

P932

Q35021702-2538F59A-EC47-4B66-BF6D-F45CC02AAD32

P356

JOURNAL.PONE.0077223

P1433

P1476

SLCO1B1 and SLC19A1 gene varia ...... f metastatic colorectal cancer

@en

P2093

Aihua Zang

http://www.w3.org/2001/XMLSchema#string

Conghua Xie

http://www.w3.org/2001/XMLSchema#string

Hong Ma

http://www.w3.org/2001/XMLSchema#string

Jigui Chen

http://www.w3.org/2001/XMLSchema#string

Jing Dai

http://www.w3.org/2001/XMLSchema#string

Juan Cai

http://www.w3.org/2001/XMLSchema#string

Jueping Feng

http://www.w3.org/2001/XMLSchema#string

Kai Qin

http://www.w3.org/2001/XMLSchema#string

Liu Huang

http://www.w3.org/2001/XMLSchema#string

Min Li

http://www.w3.org/2001/XMLSchema#string

P2860

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia.

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale.

Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.

Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis.

P304

e77223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0077223

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258061492

http://www.w3.org/2001/XMLSchema#string

P698

24143213

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3797132

http://www.w3.org/2001/XMLSchema#string